Halozyme Therapeutics shares owned by Cary Street Partner Investment Advisory
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Cary Street Partner Investment Advisory
from 13F filings
Historical chart of Cary Street Partner Investment Advisory investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Cary Street Partner Investment Advisory consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Cary Street Partner Investment Advisory
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.9M | 120k | 57.24 |
| 2024-06-30 | $1.1M | 20k | 52.36 |
| 2024-03-31 | $827k | 20k | 40.68 |
| 2023-12-31 | $752k | 20k | 36.96 |
| 2023-09-30 | $777k | 20k | 38.20 |
| 2023-06-30 | $734k | 20k | 36.07 |
| 2023-03-31 | $777k | 20k | 38.19 |
| 2022-12-31 | $1.2M | 20k | 56.90 |
| 2022-09-30 | $802k | 20k | 39.53 |
| 2022-06-30 | $890k | 20k | 44.02 |
More positions owned by Cary Street Partner Investment Advisory
View all positions for Cary Street Partner Investment Advisory